Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 1,444 shares at $256.16 ($370K) on 2016-02-17, disclosed to the SEC on 2016-02-19.
Open-market sale of $370k BIIB by EVP CMO Neuro & Neurodegenerat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.16 | 722 | $185K | 50.0% |
| 2 | $256.16 | 722 | $185K | 50.0% |
| Total | $256.16 avg | 1,444 | $370K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |